Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications

Post time 2024-5-10 15:36:52

journal：Expert Review of Clinical Pharmacology

Authors：Elisabeth Amadeo; Federico Rossari; Francesco Vitiello; Valentina Burgio; Mara Persano; Stefano Cascinu; Andrea Casadei-Gardini; Margherita Rimini

Published date：2023-7-3

DOI：10.1080/17512433.2023.2232302

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2232302

Article link：http://dx.doi.org/10.1080/17512433.2023.2232302

Article Source：Informa UK Limited。

Remark：

Post time 2024-5-10 15:36:53

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Taylor&Francis] Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Taylor&Francis] Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Taylor&Francis] Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications